Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

Recent News and Articles on the Keywords: psoriasis + ringworm + eczema  Related to the article below (Last Update: 12/1/2008)

News results: Standard Version | Text Version | Image Version

Browse Top Stories Recent Last hour Last day Past week Past month Archives All dates 2000s 1956 1950-55 1949 1948 Other dates Other dates Other dates: [hide] - Blogs News Alerts RSS | Atom About Feeds Your search - psoriasis + ringworm + eczema - did not match any documents. Suggestions: Make sure all words are spelled correctly. Try different keywords. Try more general keywords. Try fewer keywords. Try Google Blog Search. Also, you can browse today's headlines on the Google News homepage.

Recent News and Articles on the Keywords: psoriasis + 0.24 + web  Related to the article below (Last Update: 8/5/2008)

The US House of Representatives Unanimously Passes Resolution in ... istockAnalyst.com, OR - Aug 4, 2008 H.Res. 1296 passed unanimously, 404 to 0, in support of designating September as National Child Awareness Month. At the behest of Festival of Children ... August is Psoriasis Awareness Month MarketWatch - Psoriasis is a noncontagious, chronic disease of the immune system that appears on the skin, causing red, scaly patches. Many of the estimated 7.5 million ... Manhattan Falls Short on Phase II Trial for Psoriasis FDA news (subscription), VA - Manhattan Pharmaceuticals? Phase IIa clinical study of topical PTH (1-34) for the treatment of mild-to-moderate plaque psoriasis failed to improve patients? ...OTC:MHAN When health problems are skin deep Chester DailyLocal.com,  USA - Aug 4, 2008 Psoriasis, a chronic skin disorder, is one such condition. August is National Psoriasis Month, and several area medical professionals recently shared their ... PhotoMedex Reports 2008 Second Quarter Results; Announces Sale of ... FOXBusiness - "We are very pleased with the sales progress we are making with the XTRAC for the treatment of psoriasis, and believe that the recent improvement in the ...PHMD NullHap - a versatile application to estimate haplotype ... 7thSpace Interactive (press release), NY - As an example of application we used Nullhap to reanalyze published data on distribution of KIR genotypes in Polish psoriasis patients and controls showing ... Manhattan Pharmaceuticals reports encouraging results from ... Pharmaceutical Business Review - Aug 1, 2008 ... designed to assess the safety and preliminary efficacy of two dose levels of topical PTH (1-34) for the treatment of mild to moderate plaque psoriasis. ...OTC:MHAN Model Focus Vogue.com, UK - I used to have psoriasis until about 12 years ago, which has always kept me humble. But every model goes through turbulence so you have to work out what ... Study Reveals Novel LCD Solution Provides Significant Benefits ... MarketWatch - Jul 31, 2008 Specifically, results of an interim analysis reveal the LCD solution is outperforming calcipotriol cream in achieving improvement of psoriasis symptoms ... Manhattan Pharmaceuticals Announces Results of Phase 2a Study of ... MarketWatch - Jul 31, 2008 today announced top-line results from its Phase 2a clinical study of topical PTH (1-34) for the treatment of psoriasis. This multi-center, randomized, ...OTC:MHAN

Psoriasis: Picking the Perfect Plan

Even though there are records of the skin disorder psoriasis dating back 2,000 years, only recently have people with psoriasis had more than a few moderately effective treatment options. These new therapies were developed after researchers realized that psoriasis results not from the skin itself but from a malfunction in the immune system.

So today, people living with the plaques or lesions that characterize psoriasis can choose from creams or ointments, light therapy or therapies that affect the immune system such as medications known as biologics. Below, Robert Greenberg, MD, of the East Bay Psoriasis Treatment Center in San Ramon, California, talks about how to select the best therapy for your needs.

What is psoriasis?
Psoriasis is an inflammatory disease of the skin. A long time ago, it was felt to be strictly a skin disorder, but because of some studies, we realized that it's actually an immune-mediated disorder that is showing itself in the skin. It is due to circulating immune system cells called T cells that cause inflammation in the skin that leads to skin thickening and red, scaly plaques.

What are the different stages of psoriasis?
The standard definition of severe psoriasis is psoriasis covering 10 percent total body surface area. My personal belief is 20 percent total body surface area would be considered severe, 10 to 20 percent would be moderate and less than 10 percent would be on the milder side.

What are the different types of psoriasis?
There are a few types of psoriasis and they look somewhat different. The most classic is called plaque psoriasis, where you get thick, scaly, red plaques, most commonly on the elbows, knees and the scalp. Other forms are pustular psoriasis, which causes pustules or lesions all over the skin. There's a form called guttate, which is very small, round patches. And also a form called inverse psoriasis, where you get lesions under the arms and in the groin folds.

Psoriatic arthritis is often seen with psoriasis and sometimes it's seen independently. It is an inflammation of the joints. You get swelling and redness, most particularly around the fingers, but it can involve the knees and elbows.

How can psoriasis affect quality of life?
Psoriasis can be a devastating disorder. Psychologically, patients feel often like lepers; they feel that they're not part of the community. They cannot participate in activities such as swimming at their local pool, playing tennis. Even socially, on dates for example, it's very awkward.

Most patients feel that the remainder of the world is not familiar with psoriasis. People think psoriasis may be contagious and they can catch it from them. I recently had a patient who worked at a physical fitness center and many of her clients would not come back to her when she had a flare of her psoriasis.

What kinds of therapy are available?
For mild cases you usually start treatment with various topical medicines such as cortisone ointments, a vitamin D cream or retinoids, which are vitamin A derivatives.

For people with more advanced disease, therapy can include various types of light. The most popular phototherapy is called narrow-band UVB phototherapy, which is both very safe and well tolerated. There's also PUVA, which involves taking a pill first, then getting exposed to UVA light. And now we have been using light therapies that involve laser treatment, which is a UVB laser or vascular lesion lasers.

And then we get to the systemic therapies. Methotrexate, which is given either orally or as an injection, and cyclosporin, which is given orally. These medicines suppress the immune system. And now biologic therapy, a new development over the last two years, is available. Biologics are targeted therapies that affect the immune system. They are proteins that have various effects in the body and they have to be given by injection.

What factors go into making treatment decisions?
Moderate to severe psoriasis often requires systemic therapy. It is too difficult to treat with topical ointments and creams because it usually involves very large parts of the body. The various modes involve the phototherapy, which can be very effective, but difficult because patients have to come to the office a few times a week.

The methotrexate and the cyclosporin are therapies that have a lot of side effects. Methotrexate does affect the liver so people need liver biopsies after certain dosing, and cyclosporin does affect the blood pressure and the kidneys. So depending on the tolerance for risk, we may make a decision not to use one of these drugs.

The advantage of the new biologics is these side effects are very minimal. Biologics require some monitoring but they don't cause liver or kidney side effects. There are different types of biologics that are administered in different ways, which can affect someone's treatment plan. Sometimes a patient would prefer to give himself an injection at home. Other patients would prefer to have an injection at the office. These medications can also be combined with phototherapy or other medications.

Therapy with certain biologics often leads to period of time when no therapy is required. People may be going away on a summer vacation for three months, traveling, and don't want to have to give themselves injections. Many patients enjoy having this time away from their disease.

What do you consider a good response to these medications?
The response to biologics varies tremendously, anywhere from 90 percent clearing to as little as 10 to 20 percent. But many patients are very satisfied with a 50 percent reduction. Other patients feel that they need much better response; they're looking for 75 to 90 percent. A good response is mostly determined by the patients themselves. The results for the biologic agents seem to improve the longer the patient is receiving the medication, so biologics are most effective with long-term usage. People have less itching, they're comfortable, and they can wear clothes they like.